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Despite being discovered more than 15 years ago, the Borg (binder of Rho GTPases)
family of Cdc42 effector proteins (Cdc42EP1–5) remains largely uncharacterised and rela-
tively little is known about their structure, regulation and role in development and disease.
Recent studies are starting to unravel some of the key functional and mechanistic
aspects of the Borg proteins, including their role in cytoskeletal remodelling and signal-
ling. In addition, the participation of Borg proteins in important cellular processes such as
cell shape, directed migration and differentiation is slowly emerging, directly linking Borgs
with important physiological and pathological processes such as angiogenesis, neuro-
transmission and cancer-associated desmoplasia. Here, we review some of these ﬁnd-
ings and discuss future prospects.
Introduction
The Rho GTPase family member Cdc42 regulates a diverse range of cellular functions including cyto-
kinesis, cytoskeletal remodelling and cell polarity [1,2]. Like other Rho family members, Cdc42 cycles
between two tightly regulated conformational states, a GTP-bound active state and a GDP-bound
inactive state [3]. Activated Cdc42 exerts its functions by interacting with downstream effectors con-
taining a Cdc42/Rac interaction binding Q1
¶
(CRIB) motif [3,4]. Several Cdc42 effector proteins, including
kinases and scaffolds, have been well characterised [5]; however, the functions of others remain rela-
tively unknown. Still, elusive is the largely understudied Borg family of Cdc42 effector proteins,
Cdc42EP1–5 [6,7].
Borg proteins were simultaneously discovered by two independent groups as proteins that interact
with the Rho GTPases Cdc42 and TC10 Q2
¶
/RhoQ [6,7]. Using a two-hybrid screen for interactors of
TC10, the group of Ian Macara identiﬁed three clones containing identical CRIB motifs and ﬂanking
regions. Further analysis discovered the ability of these clones to bind active Cdc42 but not to Rac or
Rho GTPases. These initial clones were subsequently extended to ﬁve putative clones based on
sequence homology and their ability to bind Cdc42 in a GTP-dependent manner. They named this
new family the Borg (binder of Rho GTPases) proteins (Borg1–5). One of these clones was the previ-
ously identiﬁed MSE55 [8], which was renamed Borg5. MSE55/Borg5 had already been shown to
contain a functional CRIB domain in its N-terminus and to be a non-kinase effector protein of Cdc42
capable of inducing F-actin-based protrusions [9]. Based on these characteristics, the group of Perter
Burbelo used the amino acid sequence of MSE55/Borg5 to search for homologous sequences and
identiﬁed the same ﬁve clones [7]. They named the family ‘Cdc42 effector proteins’ or Cdc42EP/CEP,
which led to the disparate nomenclature for each member (depending on the classiﬁcation): MSE55/
Cdc42EP1/Borg5, Cdc42EP2/Borg1, Cdc42EP3/Borg2, Cdc42EP4/Borg4 and Cdc42EP5/Borg3. For
clarity, here we use the HUGO gene nomenclature to refer to each member (i.e. Cdc42EP1 instead of
MSE55/Borg5), but may use the term Borg to refer to the family.
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Structure
Borg proteins are relatively small in size, ranging from 150 amino acids (∼15.5 kDa) in Cdc42EP5 to 409
amino acids (∼39 kDa) in Cdc42EP1 (Figure 1A). No family member presents known enzymatically active
domains, which suggest that they may exert their biological functions via structural or scaffolding activities. All
Borg proteins are characterised by the presence of a highly homologous N-terminal CRIB domain (Figure 1B)
[6,7]. In Borgs, the CRIB domain presents an extension at the C-terminus that may mediate its speciﬁc binding
to active Cdc42 and TC10 but not to Rac1 [6,7], as well as determining part of the particular biological effects
of these proteins. Following the CRIB motif, there is a well-conserved short domain that is unique to Borg pro-
teins and that was deﬁned as the Borg Homology (BH) 1 domain [6]. The central and C-terminal parts of the
proteins are more divergent, but still present two additional well-conserved regions termed BH2 and BH3. The
BH2 domain is absent in the smallest Borg, Cdc42EP5, whereas the BH3 domain is common to all Borgs. The
BH3 domain has a central location in Cdc42EP1 and Cdc42EP4, whereas it is localised at the C-terminal parts
of Cdc42EP2, Cdc42EP3 and Cdc42EP5 (Figure 1C). The BH3 domain is the only BH domain with a deﬁned
molecular role and has been shown to be necessary and sufﬁcient for the speciﬁc binding of Borgs to septins
[10] (see Box 1). Contrary to the BH3 domain, the roles of the BH1 and BH2 domains are still to be deﬁned.
Figure 1. Cdc42EP/Borg family of Cdc42 effector proteins.
(A) Schematic diagram showing the different domains in all the Borg proteins. (B) Direct alignments of the CRIB domains of
murine Cdc42EP1–5, with conserved residues highlighted. (C) Direct alignments of the Q7
¶
BH3 domain of murine Cdc42EP1–5,
with conserved residues highlighted.
2 © 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
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Outside the CRIB and BH domains, sequence divergences emerge. The central regions of Cdc42EP1,
Cdc42EP2 and Cdc42EP5 present a proline-rich domain; in addition, Cdc42EP1 contains several heptad
repeats that follow the BH3 domain [10]. More recently, it has been described that Cdc42EP3 presents a puta-
tive actin-binding region in its central region, C-terminally to the BH2 domain (Figure 1A) [11]. This region
presents high homology to the actin bundling region of Anillin. This particular actin-binding region of
Cdc42EP3 is not conserved among Borg proteins; however, other Borg members may bind and/or modulate
the actin cytoskeleton by alternative mechanisms or via distinct domains.
Mode of action
AtQ3
¶
cellular and molecular levels, the function of Borg proteins remains to be clearly deﬁned, but studies thus
far indicate relevant roles in cytoskeletal rearrangement. As with other Cdc42 effector proteins, Borg proteins
were initially linked to the regulation of cell shape and early gain-of-function experiments were described roles
Box 1. The septin cytoskeleton
Septins comprise a large family of proteins (13 genes and >30 protein isoforms in humans) with
ubiquitous and tissue-speciﬁc expressions [12]. Septins are GTP-binding proteins that participate
in numerous cellular processes, including cell division, cell polarity and cytoskeletal organisation
[13,14]. Septins can dimerise and assemble into oligomers, such as the SEPT2/6/7/9 polymer,
which is the best characterised in mammalian cells [15,16]. Septin oligomers can assemble into
higher-order structures such as ﬁlaments, bundled ﬁlaments and rings, which can serve as scaf-
folds and diffusion barriers that control the localisation of cellular proteins [17]. The septin ﬁla-
mentous network can associate with cell membranes and has been shown to co-localise with
actin, tubulin and other cytoskeletal components [18,19]; thus, septins are increasingly recog-
nised as a novel component of the cytoskeleton [13]. In addition to the improved understanding
of the biochemical properties and functions of septins, a growing number of studies are highlight-
ing the relevance of septins in the development and physiology of speciﬁc tissues and organs
[12].
Table 1 The major interactions and functions of Borg proteins Q8
¶CDC42
effector
protein Interactions
Binding
partners Reported functions Key references
Cdc42EP1
(Borg5,
MSE55)
Cdc42, TC10 (RhoQ),
aPKC, ERK2, multiple
sites identified by
proteomic analysis
SEPT2/6/7 Cell shape regulation,
actomyosin contractility, cell
migration of endothelial cells
and trophectoderm cells,
directionality and
persistence, angiogenesis Q9
¶
[6,7,9,10,20,21,33,34]
Cdc42EP2
(Borg1)
Cdc42, TC10, ERK2,
ERK3, MK5
SEPT2/6/7 Cell shape regulation and
regulator of myogenesis
[6,7,10,20,32,33,37]
Cdc42EP3
(Borg2)
Cdc42, TC10, ERK3,
MK5
SEPT2/6/7
F-actin
Cell shape regulation,
actomyosin contractility and
pathological fibroblast
activation
[6,7,10,11,20,31,32]
Cdc42EP4
(Borg4)
Cdc42, TC10, PKCα SEPT2/6/7,
ARHGEF17
(TEM4)
Cell shape regulation,
filopodia formation and
mammary cell migration
[6,7,10,20,23,24]
Cdc42EP5
(Borg3)
Cdc42, ERK3, MK5 SEPT2/6/7 Cell shape regulation and
lamellipodium formation
[6,7,10,20,32]
© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). 3
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in inducing pseudopodia and F-actin-containing structures in ﬁbroblasts [7,9] and epithelial cells [7]. Shortly
after, Joberty et al. [10] elegantly demonstrated that Cdc42EP5 and Cdc42EP2 can bind septins via their BH3
domain and induce septin ﬁlament bundling. Further characterisation demonstrated that Cdc42EP5 binds spe-
ciﬁcally to SEPT6/7 heterodimers or SEPT2/6/7 trimers, but not to septin monomers [20]. This septin-binding
property has since been extended to the rest of the members of the family [11,21–23].
Not surprisingly, most Borg proteins have been shown to form ﬁlamentous structures that can co-localise
with actin ﬁbres and septin ﬁlaments (Figure 2). In normal mammary cells, Cdc42EP4 can co-localise with
actin stress ﬁbres and induce ﬁlopodia and stress ﬁbre formation [24]. In endothelial cells, Cdc42EP1 aligns
with septin ﬁlaments and actin stress ﬁbres, and depletion of Cdc42EP1 in this system disrupts both septin and
actomyosin ﬁbre assembly [21]. In ﬁbroblasts, Cdc42EP1 and Cdc42EP5 have been reported to induce lamelli-
podium formation and localise at this structure [4,6,9], hinting towards a possible role in promoting actin poly-
merisation at the leading edge of migrating cells. On the other hand, in epithelial cells, Borgs generally
distribute throughout the cell with no clear speciﬁc localisation [6,10].
All these studies suggest a functional interrelationship between Borg proteins, septin networks and the actin
cytoskeleton. Some septins (e.g. SEPT9) can bind F-actin and promote the cross-linking of pre-assembled actin
ﬁlaments [25,26], suggesting that the actin remodelling activity of Borgs might be indirect via septin rearrange-
ments. However, the association between actin and septin networks can also be potentiated by means of
adaptor proteins, such as Filamin A [27,28] and Anillin [29], that can enable septin ﬁlament assembly follow-
ing an actin template.
In a recent study investigating the cytoskeletal rearrangements regulating the emergence of pathologically
activated ﬁbroblasts (i.e. cancer-associated ﬁbroblasts or CAFs), we documented the ability of Cdc42EP3 to
bind both F-actin and septins, and to act as an adaptor protein that reinforces both networks [11]. Using
super-resolution microscopy, we observed that Cdc42EP3 forms an intricate ﬁlamentous network in CAFs that
co-localised with septin ﬁlaments. These Cdc42EP3–septin ﬁlaments clearly aligned but not exactly overlapped
with F-actin and also formed connections between actin ﬁbres. Our study demonstrated that Cdc42EP3 deple-
tion reduced the ﬁlamentous septin network in CAFs [11], an effect that was also detected after blocking stress
ﬁbre formation by depleting the well-known actin remodelling proteins DIAPH1&3 [30]. Conversely, disrupt-
ing the septin network amply affected the formation of actin stress ﬁbres. These cytoskeletal defects extensively
altered the actomyosin contractility machinery, leading to a diminished ability of CAFs to generate and sense
forces. The main consequence was a drastic inactivation of mechano-transduction signalling (i.e. FAK, Src) and
transcription (i.e. YAP), all processes dependent on intact actomyosin ﬁbres. In CAFs, Cdc42EP3 appears to
allow the template function of actin needed for septin polymerisation, as well as to enhance the F-actin cross-
linking activity of septins.
Interestingly, Cdc42EP1 presents a similar pattern of localisation in endothelial cells where Cdc42EP1 deple-
tion also leads to loss of cellular contractility and both persistent and directional migration [21], suggesting that
these particular functions may be shared by other Borg proteins. Other modes of action may be more diver-
gent. These most probably depend on primary structure differences as well as particular patterns of tissue
Figure 2. Links between Borg proteins and cytoskeletal regulation and cell shape.
Cartoon showing the cellular localisations of Borg proteins. See text for details.
4 © 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
Biochemical Society Transactions (2016) 0 1–8
DOI: 10.1042/BST20160219
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
expression that dictate speciﬁc functions and binding partners. For example, Cdc42EP4 is exclusively expressed
in Bergmann glia in the cerebellum where it localises beneath speciﬁc membrane domains. In this system,
Cdc42EP4 forms complexes with septin hetero-oligomers, which interact with and modulate a subset of glu-
tamate transporters [23]. On the other hand, in mammary epithelial cells under protein kinase Cα (PKCα)
stimulation, Cdc42EP4 dissociates from Cdc42 and binds the Rac-GEF (guanine nucleotide exchange factor)
ARHGEF17/TEM4, leading to Rac1 activation and increased motility [24].
Regulation
As other CRIB-containing Cdc42 effector proteins, Borg proteins are mainly regulated by a speciﬁc interaction
with active Cdc42-GTP [6,7]. Except for Cdc42EP5, Borg proteins can also bind activated TC10/RhoQ [6,7],
but this regulation is largely understudied and will not be reviewed here. Seminal studies demonstrated that the
cellular responses elicited by Borg proteins are Cdc42-dependent and do not require Rac1 [6,9]. Indeed,
Cdc42-binding defective mutants present diminished activities and no longer induce the characteristic morpho-
logical and cytoskeletal rearrangements of their wild-type counterparts [7,9,31]. Recently, we reported that a
Cdc42-binding defective mutant of Cdc42EP3 (Cdc42EP3-IS/AA) has lower binding afﬁnity towards actin and
septins in co-immunoprecipitation assays [11]. This mutant cannot form the characteristic ﬁlamentous
network in CAFs and shows a disperse localisation in the cytosol [31]. In addition, Cdc42EP3-IS/AA appears
to act as a dominant-negative as both actin stress ﬁbres and particularly septin ﬁlaments are amply diminished
in CAFs following Cdc42EP3-IS/AA expression. Similar results were observed in wild-type Cdc42EP3 after
ectopic expression of the dominant-negative mutant Cdc42-N17 [31]. However, ectopic expression of the con-
stitutively active mutant of Cdc42-V12 does not potentiate Cdc42EP3 functions. On the contrary, constitutive
activation of Cdc42 leads to a massive redistribution of Cdc42EP3 to Cdc42-V12-enriched vesicles. As a result,
the characteristic ﬁlamentous pattern of Cdc42EP3 and septins is lost and actin stress ﬁbres are reduced [31].
Similar results were previously reported for Cdc42EP5, where constitutive activation of Cdc42 inhibits
Cdc42EP5 binding to septins and a resultant loss of septin ﬁlaments [10]. The available data support a model
whereby interaction with active Cdc42 enables the correct positioning of Borg proteins in deﬁned subcellular
localisations where they can associate with speciﬁc binding partners (i.e. septin and/or actin) and perform their
function. In this model, the adequate cycling of Cdc42 between its GDP-bound and GTP-bound forms is
required for: (i) the ideal positioning of the Borg–Cdc42 complex in speciﬁc regions of the cell and/or (ii)
releasing Borg proteins from the complex to allow further functional interactions.
The activity of Borg proteins may also be regulated by alternative mechanisms. Cdc42EP2, Cdc42EP3 and
Cdc42EP5 are direct substrates of the atypical MAP kinases ERK3 and MK5, and have been suggested to be
relevant in the regulation of neuronal cytoskeleton and dendritic spine formation [32]. In vitro chemical–
genetic screens have also identiﬁed Cdc42EP1 and Cdc42EP2 as ERK2 substrates [33]. Cdc42EP1 has been
shown to interact with atypical PKC in mouse differentiating trophectoderm cells leading to increase cell motil-
ity [34]. In addition, Cdc42EP4 is a substrate of PKCα in human breast MCF-10A cells. PKC-mediated phos-
phorylation reduces Cdc42EP4 afﬁnity to Cdc42 allowing binding to ARHGEF17 and leading to Rac1
activation and cell migration [24]. These ﬁndings hint at a more complex scenario as they indicate that Borg
proteins may functionally interact with other Rho GTPases. Indeed, seminal studies on Borgs already suggested
a possible role of Borg proteins in partially inhibiting RhoA function and demonstrated that Borg phenotypes
can be diminished by activation of RhoA signalling [6]. Nevertheless, further studies are required to fully
understand these interactions and to delineate the exact regulatory mechanism/s controlling Borg function.
Borgs in development and disease
As opposed to other Cdc42 effectors, Borg genes are only found in vertebrates and no orthologues have been
found in bacteria, yeast, worms or ﬂies, suggesting a late emergence during evolution. In part, this may account
for the current lack of functional and biological information on these proteins. Nevertheless, functional hom-
ologous of Borg proteins are starting to emerge. For example, the yeast Cdc42 effectors Gic1 and Gic2 have
shown to possess similar functions such as septin ﬁlament assembly and cell polarity [35,36].
Thus far, it appears that Borg proteins share similar primary structures, regulatory mechanisms and modes
of action, suggesting that part of their biological relevance may be determined by their distinct patterns of
expression. Little is known about how Borg gene expression varies throughout development and adult life, but
it is evident that they are differentially expressed in tissues. Cdc42EP1 expression was initially found to be
restricted to endothelial and bone marrow stromal cells [8], with high expression levels in the microvasculature
© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). 5
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of the heart and brain [21]. Cdc42EP2 and Cdc42EP3 are preferentially expressed in the heart with reduced
levels in lung, kidney and skeletal muscle, whereas Cdc42EP5 was speciﬁcally detected in skeletal muscle [6]. As
opposed to Cdc42EP3 and Cdc42EP5, Cdc42EP2 was also detected in brain tissue [6], where expression of
Cdc42EP4 has also been recently reported, particularly in the cerebellum [23].
Some crucial functions for Borgs in development have emerged from Borg knockout mice, with some roles
also interestingly coinciding with their expression patterns. Using a Cdc42EP1-null mouse, Zheng and collea-
gues identiﬁed a critical function for Cdc42EP1 in heart development and angiogenesis. Cdc42EP1-knockout
mice showed reduced viability, as well as reduced capillary density and thinner ventricular walls [21].
Functional characterisation of cardiac endothelial cells from these mice indicated a key role of the Cdc42EP1–
septin axis in promoting angiogenesis by regulating persistent directional migration through spatial control of
actomyosin contractility. Another study by the same group also demonstrated that Cdc42EP1 also plays a role
in regulating the migration and sorting of trophectoderm cells during embryogenesis [34]. In sharp contrast,
ectopic expression of Cdc42EP2 has been reported to lead to a decrease in differentiation of mouse myoblasts,
whereas Cdc42EP2 knockdown increases myogenesis [37]. In the cerebellum, Cdc42EP4 forms complexes with
septins, which in turn interact with the glutamate transporter GLAST [23]. In Cdc42EP4 knockout mice,
GLAST dissociates from septins resulting in aberrant glutamate buffering and clearance. These defects are
accompanied by mild neural dysfunctions and impaired motor co-ordination/learning.
Even more obscure are the links between Borg proteins and disease. We recently demonstrated a key role of
Cdc42EP3 in the emergence of CAFs, stromal cells that promote tumour progression and therapeutic resistance
[38,39]. In breast cancer, Cdc42EP3 is up-regulated early in ﬁbroblast activation and co-ordinates actin and
septin rearrangements. This results in a potentiated response to chemical and mechanical stimulation that leads
to a tumour-promoting CAF phenotype [11]. More importantly, Cdc42EP3 is required for most of the hall-
marks of CAFs, notably extracellular matrix remodelling and promotion of angiogenesis, cancer cell growth
and invasion. Whether Borgs play any other roles in tumorigenesis is still to be determined. Interestingly, the
Burbelo group observed that Cdc42EP5 overexpressing keratinocytes present increased stress ﬁbres and reduced
E-cadherin expression at adherens junctions, indicative of an epithelial-to-mesenchymal transition or EMT, a
hallmark of cancer metastasis [7]. In addition, Cdc42EP3 expression is also up-regulated during a
TGF-β-induced EMT in human keratinocytes [40], and numerous studies are reporting the differential expres-
sion of Borgs in tumoural settings. Further investigation on these interesting observations is deﬁnitely required.
Conclusion
Clearly, there is still much to uncover about the biological functions of Borg proteins. In that respect, the lack
of in vivo models has hindered progress. Nevertheless, recent ﬁndings have underlined that their relevant role
in angiogenesis and pathological activation of tumour stroma, which coupled with an improved understanding
of their mode of action and regulatory mechanisms, offers a promising avenue for new research. In particular,
the identiﬁcation of Borg proteins as key regulators of septin organisation in mammalian cells may assist in the
understanding of septin functions, which is attracting a lot of attention nowadays.
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